Liquid Biopsies 2019

Home
|
Posters
|

Training Courses

|
Co-Located Conferences
|
Media
|

Conference Chairman

Lucia R. Languino
Professor of Cancer Biology, Thomas Jefferson University

Keynote Speakers

Massimo Cristofanilli Professor of Medicine, Associate Director of Translational Research and Precision Medicine, Robert H Lurie Comprehensive Cancer Center, Northwestern University	Yves A. DeClerck Professor of Pediatrics and Biochemistry & Molecular Medicine, Children’s Hospital Los Angeles, University of Southern California	Dolores Di Vizio Professor, Cedars Sinai Medical Center	Sam Hanash Director, McCombs Institute for Cancer Detection and Treatment, University of Texas MD Anderson Cancer Center	David Hoon Professor, Director Department of Translational Molecular Medicine, John Wayne Cancer Institute	Jennifer Jones NIH Stadtman Investigator, Head of Transnational Nanobiology, Laboratory of Pathology, Center for Cancer Research, National Cancer Institute
Cheng-Ho Jimmy Lin Chief Scientific Officer, Oncology, Natera	John Nolan CEO, Cellarcus Biosciences, Inc.	Balaji Panchapakesan Professor, Department of Mechanical Engineering, Worcester Polytechnic Institute (WPI)	Erkki Ruoslahti Distinguished Professor and Former President, Sanford Burnham Prebys Medical Discovery Institute	Steve Soper Foundation Distinguished Professor, Director, Center of BioModular Multi-Scale System for Precision Medicine, The University of Kansas	Shan Wang Leland T. Edwards Professor in the School of Engineering, Stanford University

Overview

SelectBIO Liquid Biopsies 2019 focuses primarily on biofluid-based molecular biomarkers, such as circulating tumor DNA (ctDNA) as well as circulating tumor cells (CTCs), and protein-based circulating biomarkers. There is much interest in the potential of ctDNA for developing biological fluid-based biopsies (such as using plasma, urine, or other biofluids) and the presenters in this track bring together the most up-to-date information and current state-of-the-field.

The conference further explores the potential of various minimally-invasive circulating biomarker classes, such as circulating-free DNA (cfDNA), CTCs, and Extracellular Vesicles (EVs), for development of novel diagnostics for early disease screening, patient monitoring and minimal residual disease detection.

This conference is held concurrently with the Circulating Biomarkers 2019 Conference enabling delegates full access to the scientific presentations in both conferences, co-located exhibit hall, and extensive networking opportunities.

Slide Deck Downloads:

Exosomes Technology Analysis Slide Deck 2018

Liquid Biopsy Slide Deck 2018

Information and Local Registration Facilities for this Conference are also available in:

Japanese |

Korean |

Chinese (Simplified) |

Chinese (Traditional)

Agenda Topics

Circulating Tumor Cells (CTCs): Potential for Development of Liquid Biopsies
Circulating Tumor DNA (ctDNA): Potential for Development of Liquid Biopsies

Emerging Technologies and Emerging Companies Showcase
Technology Platforms for Interrogation

Extracellular Nucleic Acids in the Circulation: Circulating Free DNA, Extracellular RNAs and Circulating microRNAs/Long Non-Coding RNAs
Microfluidics Platforms for Diagnostics Development
US vs. EU vs. Asia/Pacific Regulatory Landscape for Liquid Biopsies

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Distinguished Faculty

Yazhen Zhu, Assistant Professor, David Geffen School of Medicine at UCLA
Hatim Husain, Assistant Professor of Medicine, University of California San Diego
Sergio Barberan-Soler, Director of Sequencing Technologies, Somagenics, Inc
Lauren Leiman, Executive Director, Blood Profiling Atlas in Cancer (BloodPAC)
Brian Dougherty, Executive Director, Translational Genomics, Oncology IMED, AstraZeneca R&D
Kang Zhang, Founding Director, Institute for Genomic Medicine, University of California-San Diego
Kai Wang, Principal Scientist, Institute for Systems Biology
Jasmine Zhou, Professor, University of California-Los Angeles
Kun Zhang, Professor, Department of Bioengineering, University of California San Diego
Alexander Johnson-Buck, Research Assistant Professor, University of Michigan
Rachel Tam, Senior Scientific Researcher, Oncology Biomarker Development, Genentech
Jean-François Martini, Sr. Director, Translational Oncology, Immuno-Oncology, Early Development, Pfizer
Bernhard Zimmermann, Vice President of Research and Development, Natera

Corporate Sponsors	Web Sponsors	Offical Journal Partner	Networking